NexgenRx Inc. (TSXV:NXG)
0.3700
0.00 (0.00%)
Aug 13, 2025, 9:30 AM EDT
NexgenRx Revenue
NexgenRx had revenue of 4.35M CAD in the quarter ending June 30, 2025, with 6.40% growth. This brings the company's revenue in the last twelve months to 17.08M, up 11.95% year-over-year. In the year 2024, NexgenRx had annual revenue of 16.48M with 18.99% growth.
Revenue (ttm)
17.08M
Revenue Growth
+11.95%
P/S Ratio
1.54
Revenue / Employee
853.97K
Employees
20
Market Cap
26.31M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 16.48M | 2.63M | 18.99% |
Dec 31, 2023 | 13.85M | 1.07M | 8.33% |
Dec 31, 2022 | 12.78M | 939.94K | 7.94% |
Dec 31, 2021 | 11.84M | 1.27M | 12.01% |
Dec 31, 2020 | 10.57M | 1.03M | 10.82% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Curaleaf Holdings | 1.75B |
Green Thumb Industries | 1.57B |
Trulieve Cannabis | 1.62B |
Sienna Senior Living | 929.68M |
dentalcorp Holdings | 1.62B |
Cronos Group | 177.69M |
WELL Health Technologies | 990.34M |
Extendicare | 1.51B |
NexgenRx News
- 1 day ago - Nexgenrx reports Q2 results - Seeking Alpha
- 1 day ago - NexgenRx Announces Second Quarter Results with Significant Revenue Growth and Positive EBITDA - Accesswire
- 3 months ago - NexgenRx Announces First Quarter Results With Solid Revenue Growth and Positive EBITDA - Accesswire
- 4 months ago - NexgenRx (NXG) Maintains Quarterly Dividend - GuruFocus
- 4 months ago - NexgenRx declares CAD 0.005 dividend - Seeking Alpha
- 4 months ago - NexgenRx Announces Declaration of Divdend - Accesswire
- 4 months ago - Nexgenrx reports FY results - Seeking Alpha
- 4 months ago - NexgenRx Announces 2024 Year End Results with Continued Strong Revenue Growth and Increasing Positive EBITDA - Accesswire